Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nature. 1982 Nov 11;300(5888):149-52.

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Abstract

The genetic change that leads to the activation of the oncogene in T24 human bladder carcinoma cells is shown to be a single point mutation of guanosine into thymidine. This substitution results in the incorporation of valine instead of glycine as the twelfth amino acid residue of the T24 oncogene-encoded p21 protein. Thus, a single amino acid substitution appears to be sufficient to confer transforming properties on the gene product of the T24 human bladder carcinoma oncogene.

PMID:
7133135
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk